HIV test firm OraSure Technologies to raise $45 million
This article was originally published in Clinica
Executive Summary
OraSure Technologies has obtained underwriting guarantees for a planned issuance of $45m worth of stock. The Bethlehem, Pennsylvania-based company expects net proceeds to total $42m after deductions, or $48.4m net if an over-allotment option is exercised in full.